Connective tissue is considered to be composed of tightly folded polypeptide chains, resting in an extracellular amorphous ground substance consisting of polymerized muco-polysaccharides. As a result of the pioneering investigations of Meyer
Connective tissue is considered to be composed of tightly folded polypeptide chains, resting in an extracellular amorphous ground substance consisting of polymerized muco-polysaccharides. As a result of the pioneering investigations of Meyer (1) and Duran-Reynals (2), considerable investigation has been carried out concerning alterations in composition and permeability of the ground substance in diseases affecting connective tissues (3) . Alterations in the polypeptide chains responsible for the tensile strength and elasticity of connective tissue, however, have not yet been adequately studied in these diseases, nor is there any information available concerning the factors responsible for maintaining the integrity of this widely prevalent extracellular protein network. Methods suitable for clinical investigation have been lacking for investigation of this problem. We wish to report an adaptation of the hippuric acid liver function test devised by Quick (4) , which has revealed in patients with active rheumatoid arthritis abnormal metabolism of at least one of the major amino acid components of collagen. These patients fail to maintain their serum glycine within 15 per cent of the fasting value after the administration of 1.77 gm. sodium benzoate intravenously.
The basis for our observations rests upon the unique chemical composition of the proteins, collagen and elastin. Glycine constitutes 22.8 to 27.6 per cent by weight of these substances, accounting for approximately one-third of the total amino acid residues in these proteins (5) . The glycine content of these proteins is unlike that of any other human extracellular (see Table I ) or intracellular proteins whose composition has been described (6) . Any widespread increase in collagen synthesis in the body might therefore be reflected in a considerable increase in the requirements of this amino acid. Although glycine is not an essential amino acid, its rate of synthesis is so limited that dietary supplementation is necessary in birds where large amounts of collagen are needed for feather development (7) . Furthermore, excessive excretion of glycine as hippurate has been shown to limit body growth in rats (8) .
During fasting, the normal serum glycine level of 2.0 to 3.0 mg. per cent is chiefly maintained by diffusion of "readily available" glycine stored in extra-hepatic tissues, since the liver is continuously de-aminating amino acids in circulation. Glycine may also be synthesized in the liver, along with other non-essential amino acids (9) . About two-thirds of the glycine conjugated with benzoic acid in the liver, in the hippuric acid excretion test devised by Quick, comes from endogenous sources (10) . Serine, sarcosine, and glycolic acid have been shown to contribute to the formation of glycine (11) (12) (13) (14) (15) (28, 29) , and those of Weichselbaum were used for determination of hippuric acid excretion (30) .
The arthritic cases have been classified in Stages I to IV according to the classification of Steinbrocker as adopted by the New York Rheumatism Association (31) .
RESULTS
At present, 54 patients with rheumatoid arthritis in all degrees of activity and stages of disease have been studied, as well as 41 control patients, the majority of whom had hypertrophic osteo-arthritis, post-traumatic arthritis, gout or metastatic cancer (Tables II, III) . Thirty-six of the 41 control patients revealed serum glycine levels which either did not change after sodium benzoate administration, or declined less than 15 per cent at the end of one hour after injection (Figure 1) . A decline of serum glycine exceeding 15 per cent of the initial fasting level was present in five of the control patients, nearly all of whom had clinical disease of one type or another. Two patients had proven metastatic carcinoma; one was in remission following radiation and testosterone therapy. A third patient also developed a positive test with the progression of hepatic metastases of mammary adenocarcinoma. One patient suffered from decompensated portal cirrhosis with ascites, and another had post-traumatic arthritis of the acetabulum secondary to malposition resulting from an old femoral neck fracture. One patient had roentgenologic evidence of hypertrophic osteoarthritis of the spine, with a persistently normal sedimentation rate. Patients recovering from extensive infections or surgical procedures were among the few control patients whose reduction in serum glycine following benzoate administration approached but did not exceed 15 per cent.
Thirty-five of the unselected 54 patients with rheumatoid involvement showed, on initial examination, a decline of serum glycine greater than 15 per cent of the fasting value at one hour, similar to that seen in Figure 1 these patients examined on more than one occasion showed at some time a "positive" glycine response falling more than 15 per cent to levels, in some cases, less than 50 per cent of the initial values. When the total series of observations is classified according to the presence or absence of bone or joint involvement in both control patients and in rheumatoid arthritis cases, it is apparent that serum glycine lability is slightly increased in the presence of non-rheumatoid bone or joint pathology (Table III) . The changes, however, are far greater in the rheumatoid patients who, in every stage of the disease, show highly significant increases in serum glycine response. This table also illustrates the normal hippuric acid excretion throughout all groups of patients observed; indeed, the Stage I rheumatoid cases show a barely significant increase in mean hippuric acid excretion compared with that of the entire control series. The t value for this increase was 2.36, corresponding to less than 1 chance in 50 of random occurrence. Statistical evaluation of the differences in glycine response indicates that they would occur by chance in less than 1 out of 100,-000 trials. No significant differences in alanine levels were noted in either of these two groups of patients (32) . No significant abnormalities of liver function were detectable by laboratory examination in most patients in either the rheumatoid or control series. Infrequently, reduction in hippurate excretion, abnormal thymol turbidity, cephalin flocculation or inversion of the A/G ratio was noted in patients with Stage IV arthritis. Renal insufficiency was not present in any of the cases in the series.
Among the rheumatoid arthritis group, serial determinations of serum glycine response to sodium benzoate administration and of sedimentation rates were frequently carried out. Fifteen patients were observed two or more times with an interval of two or more months intervening between blood samplings. In 11 patients, the sedimentation rate varied more than 10 mm. per hour, and its changes correlated directly with the variation in glycine response to benzoate administration. An increase or decrease in the former was accompanied by a greater or lesser fall, respectively, in the level of serum glycine. In 3 patients, there was no detectable correlation, perhaps because there was less than 10 mm. change in sedimentation rates in the interval. The last patient, Stage IV arthritic, showed wide fluctuations of serum glycine response independent of his sedimentation rate.
DISCUSSION
These observations reveal that patients with active rheumatoid arthritis cannot maintain a constant serum glycine level under the load imposed by intravenous administration of 1.77 gm. sodium benzoate. The data failed to show any corresponding disturbance in hippuric acid excretion, serum alanine concentration, or in hepatic or renal function. This manifestation of altered glycine metabolism has been noted in many Stage I rheumatoid arthritics previous to the development of deformity or roentgenographic abnormalities of bones and joints. It has been noted almost exclusively in patients in whom there were good clinical grounds for suspecting pathologic changes affecting collagen, including patients with active rheumatic fever and disseminated lupus erythematosus (19) . Patients with inactive rheumatoid arthritis, inactive rheumatic fever, and discoid lupus erythematosus usually are able to maintain a serum glycine level within 15 per cent of the fasting level, similar to patients without organic disease, and those with hypertrophic osteo-arthritis only.
The decline of serum glycine from fasting levels noted in these patients might be explained by decreased reservoirs of pre-formed glycine in liver or peripheral tissues, by decreased synthesis of glycine, or by diversion of glycine from extracellular to intracellular pathways of utilization (Figure 2) . Alteration in the function of enzyme systems controlling the distribution of bound glycine either in polypeptides or in some other form might contribute to the latter possibility. No differences have been noted in the mean daily glycine intake of rheumatoid and non-rheumatoid patients.
Glycine tolerance tests have failed thus far to establish an increased rate of glycine utilization in rheumatoid arthritis. Abnormally flat tolerance curves have been reported by DeVries and Alexander in one case (33) , and by Stillman and associates in preliminary observations (34) . In neither instance were the changes in these tolerance tests shown to be specific for glycine, and absent for other amino acids. Many of the alternative processes utilizing glycine in rheumatoid arthritis appear to be depressed rather than increased (Figure 2 ). The presence of weight loss, anemia, hypo-albuminemia, muscular weakness and atrophy, cutaneous dystrophy (accompanying psoriatic skin manifestations), and cutaneous atrophy in advanced rheumatoid arthritis speak for reduced purine, hemoglobin, creatine, and keratin synthesis compared to normal. Only the synthesis of collagen appears to be increased in some of these cases, as a part of the reparative processes (37) .
Both clinical and laboratory evidence therefore favor an extrahepatic source for the abnormalities noted in glycine metabolism in patients with rheumatoid arthritis and allied conditions. Further investigation is necessary to determine whether there are alterations in enzyme mechanisms releasing it to the blood stream, or using it for protein synthesis.
These observations of altered amino acid metabolism in rheumatoid arthritis have important etiologic and therapeutic implications that cannot be overlooked. Because of the uniquely small size of glycine residues, relative to those derived from other amino acids, the high concentrations of glycine in collagen and elastin have often been thought significant in influencing the characteristic configurations and modes of packing of the polypeptide chains in these fibrous proteins (38, 39 (40, 41) . Many of our rheumatoid patients showed chronic anxiety, and the early cases in Stage I excreted more hippurate than did controls or those with more advanced disease (Table III) . Severe emotional trauma superimposed upon chronic anxiety and insecurity is among the predisposing mental conditions favoring the onset of rheumatoid arthritis (42) .
Re-evaluation of nutritional factors would appear to be important in the prevention and treatment of the rheumatoid group of diseases, not only because of these findings, but because of the limited daily intake of and synthetic capacity for glycine compared to its manifold pathways for utilization in essential processes (Figure 2 ). Although therapy with cortisone and ACTH delays the uptake of amino acids by rat cells (43), we have failed to note in our patients treated with these compounds any immediate improvement in abnormal serum glycine response. Spontaneous disease remissions, however, are often associated with return to a normal response curve.
SUM MARY
The administration of sodium benzoate to patients with active rheumatoid arthritis results in a decline of more than 15 per cent in the fasting level of serum glycine in the majority of cases, which persists for at least one hour. Similar changes have been observed in patients with active rheumatic fever and disseminated lupus erythematosus. Serum glycine remains constant in healthy persons or patients with hypertrophic osteo-arthritis. Because of the uniquely high concentration of glycine in collagen and elastin (22.8 to 27.6 per cent) and the fact that abnormal response of serum glycine to benzoate administration has been noted chiefly in diseases characterized by pathology of collagen, this test may be indicative of a metabolic abnormality affecting connective tissues. Evaluation of the response of serum glycine to benzoate administration may assist in the objective evaluation of patients with arthritic symptoms and in the earlier recognition of rheumatoid arthritis.
